Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

119.60
+0.03000.03%
Post-market: 119.600.00000.00%19:31 EDT
Volume:634.88K
Turnover:76.17M
Market Cap:12.93B
PE:263.64
High:122.00
Open:119.00
Low:117.23
Close:119.57
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:0.70
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:18.32
PE(LYR):145.85

Loading ...

Premarket Movers | CORT Surges 26% as Q2 Earnings Easily Beat Expectations and Full-Year Guidance Is Raised

Market Focus
·
Jul 30

Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $161 from $150

THOMSON REUTERS
·
Jul 30

Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know

Benzinga Earnings
·
Jul 30

Movement Alert|Corcept Therapeutics Overnight Rise 20.02%, Q2 Earnings Massively Beat Expectations with Raised Full-Year Guidance

Market Focus
·
Jul 30

Stock Track | Corcept Therapeutics Soars 25.20% in 24 Hours as Q2 Earnings Massively Beat, Guidance Raised

Stock Track
·
Jul 30

Corcept Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Stock Track | Corcept Therapeutics Soars 18.34% in After-Hours Trading After Q2 Earnings Massively Beat Estimates

Stock Track
·
Jul 30

Movement Alert|Corcept Therapeutics Rises 18.34% in After-Hours Trading, Q2 Earnings Significantly Beat Expectations

Market Focus
·
Jul 30

GUIDANCE: (CORT) Corcept Therapeutics Expects Full Year 2026 Revenue Range $1.1B - $1.2B, vs. FactSet Est of $999.5M

MT Newswires Live
·
Jul 30

Earnings Flash (CORT) Corcept Therapeutics Posts Q2 EPS $0.36, vs. FactSet Est of $0.02

MT Newswires Live
·
Jul 30

Corcept Therapeutics Q2 EPS USD 0.36

Reuters
·
Jul 30

Corcept Q2 FY26 Net Income Rises to $43 Million; Revenue Climbs 32% to $256.1 Million

Reuters
·
Jul 30

Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook

Reuters
·
Jul 30

Corcept Therapeutics Q2 EPS $0.36 Beats $(0.00) Estimate, Sales $256.147M Beat $219.988M Estimate

Benzinga Earnings
·
Jul 30

Corcept Therapeutics is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 30

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $150 from $135

THOMSON REUTERS
·
Jul 29

Corcept Therapeutics Cut to Underperform from Peer Perform by Wolfe Research

Dow Jones
·
Jul 27

Top Growth Companies With Insider Ownership For July 2026

Simply Wall St.
·
Jul 27

Movement Alert|Corcept Therapeutics Rises 5.36% in Regular Trading, Cushing Syndrome NDA Resubmission and Earnings Expectations Boost Sentiment

Market Focus
·
Jul 24